VE
VEE.F Veeva Systems Inc
- Market cap
- EUR 47.3B
- P/E
- 71.7x
- P/B
- 5.76x
- ROE
- 14.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jul 2026.
Is VEE.F undervalued?
Graham numberThe Graham number of Veeva Systems Inc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Veeva Systems Inc fundamental analysis
No fundamental analysis for Veeva Systems Inc yet.
Veeva Systems Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Veeva Systems Inc
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Cros…
Full company profileVeeva Systems Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Veeva Systems Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 544M | 686M | 862M | 1.10B | 1.47B | 1.85B | 2.16B | 2.36B | 2.75B | 3.20B | 3.62B |
| Gross Profit | 370M | 474M | 617M | 801M | 1.06B | 1.35B | 1.55B | 1.69B | 2.05B | 2.41B | 2.72B |
| Operating Income | 108M | 151M | 223M | 286M | 378M | 505M | 459M | 429M | 691M | 916M | 1.10B |
| EBITDA | - | 165M | 237M | 306M | 407M | 533M | 488M | 462M | 731M | 954M | 1.14B |
| Net Income | 68.8M | 142M | 230M | 301M | 380M | 427M | 488M | 526M | 714M | 909M | 1.07B |
| EPS | - | 1.00 | 1.57 | 2.02 | 2.50 | 2.78 | 3.08 | 3.26 | 4.39 | 5.55 | 6.60 |
| Balance Sheet | |||||||||||
| Total Assets | 918M | 1.20B | 1.65B | 2.27B | 3.05B | 3.82B | 4.80B | 5.91B | 7.34B | 8.98B | 9.06B |
| Total Liabilities | 265M | 325M | 416M | 606M | 780M | 905M | 1.09B | 1.27B | 1.51B | 1.76B | 1.63B |
| Shareholders' Equity | 653M | 872M | 1.24B | 1.67B | 2.27B | 2.91B | 3.72B | 4.64B | 5.83B | 7.21B | 7.43B |
| Cash & Short-term Investments | 218M | 320M | 551M | 477M | 731M | 1.14B | 886M | 703M | 1.12B | 1.42B | 1.81B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 144M | 233M | 311M | 437M | 551M | 764M | 780M | 911M | 1.09B | 1.42B | 2.73B |
| Capital Expenditure | 7.51M | 9.63M | 9.82M | 4.32M | 8.68M | 14.2M | 13.5M | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | 222M | 301M | 433M | 551M | 764M | 780M | 911M | 1.09B | 1.42B | 2.73B |
| Ratios | |||||||||||
| ROE | 10.5% | 16.3% | 18.6% | 18.1% | 16.8% | 14.7% | 13.1% | 11.3% | 12.2% | 12.6% | 14.4% |
| ROA | 7.5% | 11.9% | 13.9% | 13.3% | 12.5% | 11.2% | 10.2% | 8.9% | 9.7% | 10.1% | 11.8% |
| Net Profit Margin | 12.6% | 20.7% | 26.7% | 27.3% | 25.9% | 23.1% | 22.6% | 22.2% | 26.0% | 28.4% | 29.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Veeva Systems Inc dividends
Veeva Systems Inc has not paid dividends in the last 9 fiscal years.
Who owns Veeva Systems Inc
- Insiders 8.62%
- Institutions 91.38%
- Public & others 0.00%
- Shares outstanding 163M
- Free float 148M
Veeva Systems Inc company profile
- Company name
- Veeva Systems Inc
- Ticker
- VEE.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 7,928
- Fiscal year end
- January
- Address
- 4280 Hacienda Drive, Pleasanton, CA, United States, 94588
- Phone
- 925 452 6500
- Website
- veeva.com
About Veeva Systems Inc
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Veeva Systems Inc management
10- Mr. Peter P. GassnerFounder, CEO & Director · born 1965
- Ms. Eleni Nitsa ZuppasPresident & Chief of Staff · born 1970
- Mr. Brian Van WagenerChief Financial Officer · born 1983
- Mr. Vipin KondathChief Accounting Officer · born 1976
- Ms. Catherine AllshouseChief Information Officer
- Mr. Gunnar Georg HansenDirector of Investor Relations
- Mike WokaschVice President & General Counsel
- Mr. Dan RizzoEVP of Sales, Consulting & Services
- Ms. Vivian WelshChief People Officer
- Mr. Paul ShawahExecutive Vice President of Strategy & Campaign Manager